Representative Image
COVID infection for those below 18 years of age during second wave less than 13 pc: NHM Assam ANI | Updated: Jun 29, 2021 05:40 IST
Dispur (Assam) [India], June 29 (ANI): National Health Mission, Assam on Monday evening informed that during the second wave, the COVID-19 infection rate for those aged below 18 years of age is less than 13 per cent.
An official document by the health mission stated, From 1/04/2021 to 26/06/2021, the total number of COVID infected persons in Assam has been 2,80,504. Out of this, 34,606 within the age group of 0 to 18 years were found infected with COVID 19. Further analysis showed that a total of 5,755 cases belonged to less than 5 years and 28,851 to 6 to 18 years age groups.
Assam Records 96.67% Covid Spike Among Below 18 Age Group In 2nd Wave Assam Records 96.67% Covid Spike Among Below 18 Age Group In 2nd Wave Assam also witnessed over three times increase in deaths of the below 18 year age group of which 55 per cent were toddlers - 0 to 5 years age group.
Assam as a whole has recorded 27,8069 new cases in the second wave of COVID-19. (File)
Assam has recorded an alarming 96.67 per cent rise in COVID-19 infection among children and teenagers below 18 years from the first wave to the second wave of the pandemic, even though the state has seen only a 27.31 per cent rise in the total number of cases.
34, 606 people within the age group of 0 to 18 years found infected by COVID-19 in Assam indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Share:
New York, June 09, 2021 (GLOBE NEWSWIRE)
Major factors driving market revenue growth include increasing use of stem cells to treat various diseases, rising stem cell-based research activities, and growing funding for stem cell-based research.
Market Size – USD 17.05
in 2020 Market Growth – 6.8%
Market Trends – Technological advancements in cell therapy and an increased emphasis on the development of personalized medicines
The global
stem cell manufacturing market size is expected to reach USD 28.85 billion in 2028, registering a CAGR of 6.8% over the forecast period, according to the latest report by Reports and Data. Major factors driving market revenue growth include increasing use of stem cells to treat various diseases, rising stem cell-based research activities, and growing funding from private and public organizations for stem cell-based research. Technological advancements in cell therapy and an increased emphasis on the development of personalized me